Publications

• Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin.
  Commun Biol Volume: 7 Page(s): 426
  04/08/2024 Authors: Mittal K; Cooper GW; Lee BP; Su Y; Skinner KT; Shim J; Jonus HC; Kim WJ; Doshi M; Almanza D
• A phase 1 study of simvastatin in combination with topotecan and cyclophosphamide in pediatric patients with relapsed and/or refractory solid and CNS tumors.
  Volume: 70 Page(s): e30405
  08/01/2023 Authors: Cash T; Jonus HC; Tsvetkova M; Beumer JH; Sadanand A; Lee JY; Henry CJ; Aguilera D; Harvey RD; Goldsmith KC
• Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma.
  Cell Rep Med Volume: 4 Page(s): 101091
  06/20/2023 Authors: Lee JY; Jonus HC; Sadanand A; Branella GM; Maximov V; Suttapitugsakul S; Schniederjan MJ; Shim J; Ho A; Parwani KK
• The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1.
  Oncoimmunology Volume: 12 Page(s): 2240678
  01/01/2023 Authors: Pilgrim AA; Jonus HC; Ho A; Cole AC; Shim J; Goldsmith KC
• Dissecting the cellular components of ex vivo T cell expansions to optimize selection of potent cell therapy donors for neuroblastoma immunotherapy trials.
  Oncoimmunology Volume: 11 Page(s): 2057012
  01/01/2022 Authors: Jonus HC; Burnham RE; Ho A; Pilgrim AA; Shim J; Doering CB; Spencer HT; Goldsmith KC
• High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.
  Mol Cancer Ther Volume: 20 Page(s): 1161 - 1172
  06/01/2021 Authors: Vernooij L; Bate-Eya LT; Alles LK; Lee JY; Koopmans B; Jonus HC; Schubert NA; Schild L; Lelieveld D; Egan DA
• YAP-Mediated Repression of HRK Regulates Tumor Growth, Therapy Response, and Survival Under Tumor Environmental Stress in Neuroblastoma.
  Cancer Res Volume: 80 Page(s): 4741 - 4753
  11/01/2020 Authors: Shim J; Lee JY; Jonus HC; Arnold A; Schnepp RW; Janssen KM; Maximov V; Goldsmith KC
• Thiamine mimetics sulbutiamine and benfotiamine as a nutraceutical approach to anticancer therapy.
  Biomed Pharmacother Volume: 121 Page(s): 109648
  01/01/2020 Authors: Jonus HC; Byrnes CC; Kim J; Valle ML; Bartlett MG; Said HM; Zastre JA
• Development of an IPRP-LC-MS/MS method to determine the fate of intracellular thiamine in cancer cells.
  J Chromatogr B Analyt Technol Biomed Life Sci Volume: 1124 Page(s): 247 - 255
  08/15/2019 Authors: Kim J; Jonus HC; Zastre JA; Bartlett MG
• The adaptive regulation of thiamine pyrophosphokinase-1 facilitates malignant growth during supplemental thiamine conditions.
  Oncotarget Volume: 9 Page(s): 35422 - 35438
  10/23/2018 Authors: Jonus HC; Hanberry BS; Khatu S; Kim J; Luesch H; Dang LH; Bartlett MG; Zastre JA